机器人辅助与传统腹腔镜治疗I期子宫内膜癌的长期生存结局:美国国家癌症数据库分析
本研究基于美国国家癌症数据库的回顾性队列,纳入2010至2017年诊断的127,342例接受微创手术的I期子宫内膜癌患者,比较机器人辅助与传统腹腔镜的总生存(OS)。中位随访69.7个月,两组5年OS分别为91.7%与91.4%,校正后HR=1.00(95%CI 0.96-1.04),未见OS差异。
要点
- I期子宫内膜癌微创手术中,机器人辅助与传统腹腔镜的总生存无差异。
- 校正人口学与临床因素后,HR=1.00(95%CI 0.96-1.04)。
- 5年OS:机器人辅助91.7%,传统腹腔镜91.4%。
核心结论
- I期子宫内膜癌患者接受机器人辅助与传统腹腔镜手术的总生存无差异,数据不倾向于任一手术路径。
研究设计与样本
- 回顾性队列研究,使用美国国家癌症数据库,纳入2010至2017年诊断的I期子宫内膜癌患者,随访至2020年。
- 共纳入127,342例接受微创手术的患者,其中机器人辅助手术占74.5%,传统腹腔镜手术占25.5%。
- 存活患者的中位随访时间为69.7个月。
主要发现
- 两组人口学与临床因素相似。
- 5年总生存率:机器人辅助组91.7%,传统腹腔镜组91.4%。
- 校正人口学与临床因素后,总生存的风险比HR=1.00(95%CI 0.96-1.04)。
临床怎么用
- 对于I期子宫内膜癌的微创手术,机器人辅助与传统腹腔镜均可选择,长期总生存结局相当。
局限性
- 鉴于潜在晚期复发和死亡,手术路径决策的完整影响可能未被完全检测。
- 需要大规模、前瞻性、长期随访研究进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare the long-term survival outcomes of robotic-assisted versus traditional laparoscopic surgery for treatment of stage I endometrial cancer. METHODS: We performed a retrospective cohort study using the National Cancer Database, including patients with stage I endometrial cancer diagnosed from 2010 to 2017 (with follow-up through 2020) who underwent treatment with either robotic-assisted or traditional laparoscopic surgery. Demographics, clinical characteristics, and outcomes were summarized using descriptive statistics. Overall survival (OS) was compared using a Cox proportional hazard model, adjusting for demographic and clinical factors; hazard ratios and 95% confidence intervals reported. RESULTS: A total of 127,342 patients with stage I endometrial cancer who underwent minimally invasive surgery were included. The median follow-up among those still known to be alive was 69.7 months. Almost three-quarters (74.5%) received robotic-assisted surgery, while 25.5% received traditional laparoscopic surgery. Demographic and clinical factors were similar between groups. No differences in OS were observed by surgery modality (5-year OS: 91.7% for robotic vs. 91.4% for traditional laparoscopic surgery) and this remained after adjustment for demographic and clinical factors (HR = 1.00, 95% CI 0.96-1.04). CONCLUSIONS: There was no difference in OS for patients with stage I endometrial cancer treated with robotic-assisted versus traditional laparoscopic surgery. These data demonstrate excellent survival outcomes in this cohort and do not favor a robotic-assisted or traditional laparoscopic approach. However, the full extent of a route-of-surgery decision may not be detected given the potential for late recurrences and deaths, highlighting the need for large, prospective studies with long duration of follow-up.
引用
- Boyle SJ, Dona A, Vogel RI, et al. Long-term survival outcomes of robotic-assisted versus traditional laparoscopy for the treatment of stage I endometrial cancer: a National Cancer Database analysis. Gynecol Oncol. 2026. PMID: 41844495. doi:10.1016/j.ygyno.2026.02.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。